INVESTOR ACTION ALERT The Schall Law Firm Announces it is Investigating Claims Against New Relic, Inc. and Encourages Investors with Losses to Contact the Firm
| SSYGX Fund | USD 43.01 0.15 0.35% |
Slightly above 53% of Dreyfus/the Boston's investor base is interested to short. The analysis of overall sentiment of trading Dreyfusthe Boston Pany mutual fund suggests that many investors are impartial at this time. Dreyfus/the Boston's investing sentiment can be driven by a variety of factors including economic data, Dreyfus/the Boston's earnings reports, geopolitical events, and overall market trends.
Dreyfus/the |
LOS ANGELES, CA ACCESSWIRE August 29, 2023 The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in New Relic, Inc.
Read at accesswire.com
 |
Dreyfus/the Boston Fundamental Analysis
We analyze Dreyfus/the Boston's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus/the Boston using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus/the Boston based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Dreyfusthe Boston is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Dreyfusthe Boston Pany Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus/the Boston mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus/the Boston could also be used in its relative valuation, which is a method of valuing Dreyfus/the Boston by comparing valuation metrics with similar companies.
Peers
Dreyfus/the Boston Related Equities
| RYHCX | Health Care | 0.63 | ||||
| RAGHX | Allianzgi Health | 0.38 | ||||
| GGHYX | Invesco Global | 0.22 | ||||
| FHCCX | Fidelity Advisor | 0.14 | ||||
| ETAHX | Eventide Healthcare | 0.17 |
Other Information on Investing in Dreyfus/the Mutual Fund
Dreyfus/the Boston financial ratios help investors to determine whether Dreyfus/the Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus/the with respect to the benefits of owning Dreyfus/the Boston security.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |